Expression of Prox1 during mouse cochlear development
Version of Record online: 14 MAR 2006
Copyright © 2006 Wiley-Liss, Inc.
Journal of Comparative Neurology
Volume 496, Issue 2, pages 172–186, 10 May 2006
How to Cite
Bermingham-McDonogh, O., Oesterle, E. C., Stone, J. S., Hume, C. R., Huynh, H. M. and Hayashi, T. (2006), Expression of Prox1 during mouse cochlear development. J. Comp. Neurol., 496: 172–186. doi: 10.1002/cne.20944
- Issue online: 14 MAR 2006
- Version of Record online: 14 MAR 2006
- Manuscript Accepted: 26 NOV 2005
- Manuscript Revised: 11 OCT 2005
- Manuscript Received: 6 JUN 2005
- National Institutes of Health. Grant Numbers: DC005953, DC003944, DC003696, DC006437
- National Institute on Deafness and Other Communication Disorders. Grant Number: P30 DC004661
- National Institute of Child Health and Human Development. Grant Number: P30 HD002274
- National Aeronautics and Space Administration. Grant Number: NAG-2-1415
- Virginia Merrill Bloedel Hearing Research Center Hearing Regeneration Initiative
This article includes Supplementary Material available via the Internet at http://www.interscience.wiley.com/jpages/0021-9967/suppmat .
|jws-cne.20944.tif||5379K||Figure S1. This figure illustrates the specificity of the Prox1 antiserum. Panel A shows Prox1 staining in E14 lens. Panel B shows Prox1 staining (red) in the organ of Corti at E18 and panel C shows that the Prox1 staining is completely eliminated by incubation with the peptide (50&#x03bc;g/ml) against which the antiserum was raised. Staining with the MyosinVIIA antibody (green) is not affected by the addition of the peptide.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.